State Street Corp's Strategic Acquisition in Vir Biotechnology Inc

Published on 18 Oct 2024 on GuruFocus.com · via Yahoo Finance

On September 30, 2024, State Street Corp made a significant addition to its investment portfolio by...

Read the rest of the article

Start tracking your investments with Statfolio

Vir Biotechnology Inc (VIR) reports increased R&D expenses due to the Sanofi transaction, while...

GuruFocus.com · via Yahoo Finance 2 Nov 2024

On September 30, 2024, State Street Corp made a significant addition to its investment portfolio ...

GuruFocus.com · via Yahoo Finance 18 Oct 2024

Shareholders in Vir Biotechnology, Inc. (NASDAQ:VIR) may be thrilled to learn that the analysts h...

Simply Wall St. via Yahoo Finance 8 May 2024

Vir Biotechnology, Inc. (VIR) closed the last trading session at $10.22, gaining 7.7% over the pa...

Zacks via Yahoo Finance 7 May 2024

Vir Biotechnology, Inc. (NASDAQ:VIR) Q1 2024 Earnings Call Transcript May 3, 2024 Vir Biotechnolo...

Insider Monkey via Yahoo Finance 3 May 2024

Key Insights Institutions' substantial holdings in Vir Biotechnology implies that they have signi...

Simply Wall St. via Yahoo Finance 28 Apr 2024

Vir Biotechnology Inc (NASDAQ:VIR), a company focused on the research and development of treatmen...

GuruFocus.com via Yahoo Finance 5 Apr 2024

Vir Biotechnology, Inc. (VIR) delivered earnings and revenue surprises of 24.56% and 31.69%,...

Zacks · via Yahoo Finance 1 Mar 2024

Shares of Vir Biotechnology, Inc. (VIR) have gained 6.2% over the past four weeks to close the la...

Zacks via Yahoo Finance 23 Feb 2024

Vir Biotechnology, Inc. (NASDAQ:VIR) Q4 2023 Earnings Call Transcript February 22, 2024 Vir Biote...

Insider Monkey via Yahoo Finance 23 Feb 2024